Koa Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Koa Wealth Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.16M	Sell	2,228 -419	-16%	-$215K	0.75%	30
2026 Q2	$1.31M	Buy	2,647 +179	+7%	+$79.3K	0.89%	33
2026 Q1	$1.1M	Sell	2,468 -115	-4%	-$53.6K	0.8%	34
2025 Q4	$1.17M	Sell	2,583 -11	-0.4%	-$4.74K	0.8%	32
2025 Q3	$1.02M	Buy	2,594 +414	+19%	+$173K	0.75%	34
2025 Q2	$971K	Buy	2,180 +108	+5%	+$49.8K	0.77%	35
2025 Q1	$1M	Buy	+2,072	New	+$966K	0.81%	33

Other funds holding VRTX

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

AMF Tjänstepension Stockholm, Sweden $17.2B AUM 28.3% 1-Year Est. Return

Bank Julius Baer & Co Zurich, Switzerland $39.3B AUM 31.81% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return

Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Koa Wealth Management's VRTX Position: Q3 2026 in Review

Koa Wealth Management reduced its Vertex Pharmaceuticals (VRTX) stake by 16% in Q3 2026, selling an estimated $215K and leaving 2,228 shares worth $1.16M. The position accounts for 0.75% of the portfolio, ranked #30.

Koa Wealth Management first reported a position in VRTX in Q1 2025 and has held it in 7 quarters since. The position peaked at $1.31M in Q2 2026. 700 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

Koa Wealth Management held 2,228 shares of Vertex Pharmaceuticals worth $1.16M as of Q3 2026.
Koa Wealth Management sold 419 Vertex Pharmaceuticals shares in Q3 2026, an estimated $215K.
Vertex Pharmaceuticals made up 0.75% of Koa Wealth Management's portfolio in Q3 2026, its #30 holding.
Koa Wealth Management first reported a position in Vertex Pharmaceuticals in Q1 2025 and has held it in 7 quarters since.
Koa Wealth Management's Vertex Pharmaceuticals position peaked at $1.31M in Q2 2026.
700 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Koa Wealth Management's 13F filing for Q3 2026, filed 14 Oct 2026.